Mena deficiency delays tumor progression and decreases metastasis in polyoma middle-T transgenic mouse mammary tumors

Breast Cancer Research

Volumn 12, Issue 6, 2010, Pages

  Roussos, Evanthia T ^a   Wang, Yarong ^a   Wyckoff, Jeffrey B ^a   Sellers, Rani S ^a   Wang, Weigang ^a   Li, Jiufeng ^a   Pollard, Jeffrey W ^a   Gertler, Frank B ^b   Condeelis, John S ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN BINDING PROTEIN; EPIDERMAL GROWTH FACTOR; MAMMALIAN ENABLED; ONCOPROTEIN; UNCLASSIFIED DRUG; CYTOSKELETON PROTEIN; ENAH PROTEIN, MOUSE; VIRUS T ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CELL MOTILITY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; INTRAVITAL MULTIPHOTON MICROSCOPY; LUNG METASTASIS; MAMMALIAN ENABLED DEFICIENCY; MAMMARY GLAND; METASTASIS; MICROSCOPY; MORBIDITY; MOUSE; NONHUMAN; POLYOMA VIRUS; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSGENIC MOUSE; WILD TYPE; ANIMAL; DISEASE COURSE; EXPERIMENTAL NEOPLASM; GENETICS; HISTOLOGY; LUNG TUMOR; MACROPHAGE; METABOLISM; MOUSE MAMMARY TUMOR ONCOVIRUS; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; PRENATAL DEVELOPMENT; TUMOR MICROENVIRONMENT; UDDER;

ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; CYTOSKELETAL PROTEINS; DISEASE PROGRESSION; EPIDERMAL GROWTH FACTOR; FEMALE; GENE EXPRESSION; LUNG NEOPLASMS; MACROPHAGES; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MAMMARY TUMOR VIRUS, MOUSE; MICE; MICE, SCID; MICE, TRANSGENIC; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; POLYMERASE CHAIN REACTION; TUMOR MICROENVIRONMENT;

EID: 78649333297     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr2784     Document Type: Article

References (64)

1. Allan AL, Vantyghem SA, Tuck AB, Chambers AF. Tumor dormancy and cancer stem cells: implications for the biology and treatment of breast cancer metastasis. Breast Dis 2006, 26:87-98.
2. Wyckoff JB, Wang Y, Lin EY, Li JF, Goswami S, Stanley ER, Segall JE, Pollard JW, Condeelis J. Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res 2007, 67:2649-2656. 10.1158/0008-5472.CAN-06-1823, 17363585.
3. Wyckoff J, Wang W, Lin EY, Wang Y, Pixley F, Stanley ER, Graf T, Pollard JW, Segall J, Condeelis J. A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res 2004, 64:7022-7029. 10.1158/0008-5472.CAN-04-1449, 15466195.
4. Goswami S, Sahai E, Wyckoff JB, Cammer M, Cox D, Pixley FJ, Stanley ER, Segall JE, Condeelis JS. Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. Cancer Res 2005, 65:5278-5283. Erratum: Cancer Res 2005, 65:7031, 10.1158/0008-5472.CAN-04-1853, 15958574.
5. Goswami S, Philippar U, Sun D, Patsialou A, Avraham J, Wang W, Di Modugno F, Nistico P, Gertler FB, Condeelis JS. Identification of invasion specific splice variants of the cytoskeletal protein Mena present in mammary tumor cells during invasion in vivo. Clin Exp Metastasis 2009, 26:153-159. 10.1007/s10585-008-9225-8, 18985426.
6. Goswami S, Wang W, Wyckoff JB, Condeelis JS. Breast cancer cells isolated by chemotaxis from primary tumors show increased survival and resistance to chemotherapy. Cancer Res 2004, 64:7664-7667. 10.1158/0008-5472.CAN-04-2027, 15520165.
7. Wang W, Eddy R, Condeelis J. The cofilin pathway in breast cancer invasion and metastasis. Nat Rev Cancer 2007, 7:429-440. 10.1038/nrc2148, 17522712.
8. Wang W, Goswami S, Lapidus K, Wells AL, Wyckoff JB, Sahai E, Singer RH, Segall JE, Condeelis JS. Identification and testing of a gene expression signature of invasive carcinoma cells within primary mammary tumors. Cancer Res 2004, 64:8585-8594. 10.1158/0008-5472.CAN-04-1136, 15574765.
9. Wang W, Mouneimne G, Sidani M, Wyckoff J, Chen X, Makris A, Goswami S, Bresnick AR, Condeelis JS. The activity status of cofilin is directly related to invasion, intravasation, and metastasis of mammary tumors. J Cell Biol 2006, 173:395-404. 10.1083/jcb.200510115, 2063840, 16651380.
10. Wang W, Wyckoff JB, Goswami S, Wang Y, Sidani M, Segall JE, Condeelis JS. Coordinated regulation of pathways for enhanced cell motility and chemotaxis is conserved in rat and mouse mammary tumors. Cancer Res 2007, 67:3505-3511. 10.1158/0008-5472.CAN-06-3714, 17440055.
11. Di Modugno F, Mottolese M, Di Benedetto A, Conidi A, Novelli F, Perracchio L, Venturo I, Botti C, Jager E, Santoni A, Natali PG, Nistico P. The cytoskeleton regulatory protein hMena (ENAH) is overexpressed in human benign breast lesions with high risk of transformation and human epidermal growth factor receptor-2-positive/hormonal receptor-negative tumors. Clin Cancer Res 2006, 12:1470-1478. 10.1158/1078-0432.CCR-05-2027, 16533770.
12. Robinson BD, Sica GL, Liu YF, Rohan TE, Gertler FB, Condeelis JS, Jones JG. Tumor microenvironment of metastasis in human breast carcinoma: a potential prognostic marker linked to hematogenous dissemination. Clin Cancer Res 2009, 15:2433-2441. 10.1158/1078-0432.CCR-08-2179, 19318480.
13. Gurzu S, Jung I, Prantner I, Chira L, Ember I. The immunohistochemical aspects of protein Mena in cervical lesions. Rom J Morphol Embryol 2009, 50:213-216.
14. Gurzu S, Jung I, Prantner I, Ember I, Pavai Z, Mezei T. The expression of cytoskeleton regulatory protein Mena in colorectal lesions. Rom J Morphol Embryol 2008, 49:345-349.
15. Pino MS, Balsamo M, Di Modugno F, Mottolese M, Alessio M, Melucci E, Milella M, McConkey DJ, Philippar U, Gertler FB, Natali PG, Nistico P. Human Mena+11a isoform serves as a marker of epithelial phenotype and sensitivity to epidermal growth factor receptor inhibition in human pancreatic cancer cell lines. Clin Cancer Res 2008, 14:4943-4950. 10.1158/1078-0432.CCR-08-0436, 2586967, 18676769.
16. Krause M, Dent EW, Bear JE, Loureiro JJ, Gertler FB. Ena/VASP proteins: regulators of the actin cytoskeleton and cell migration. Annu Rev Cell Dev Biol 2003, 19:541-564. 10.1146/annurev.cellbio.19.050103.103356, 14570581.
17. Gertler FB, Niebuhr K, Reinhard M, Wehland J, Soriano P. Mena, a relative of VASP and Drosophila Enabled, is implicated in the control of microfilament dynamics. Cell 1996, 87:227-239. 10.1016/S0092-8674(00)81341-0, 8861907.
18. Bear JE, Svitkina TM, Krause M, Schafer DA, Loureiro JJ, Strasser GA, Maly IV, Chaga OY, Cooper JA, Borisy GG, Gertler FB. Antagonism between Ena/VASP proteins and actin filament capping regulates fibroblast motility. Cell 2002, 109:509-521. 10.1016/S0092-8674(02)00731-6, 12086607.
19. Barzik M, Kotova TI, Higgs HN, Hazelwood L, Hanein D, Gertler FB, Schafer DA. Ena/VASP proteins enhance actin polymerization in the presence of barbed end capping proteins. J Biol Chem 2005, 280:28653-28662. 10.1074/jbc.M503957200, 1747414, 15939738.
20. Pasic L, Kotova T, Schafer DA. Ena/VASP proteins capture actin filament barbed ends. J Biol Chem 2008, 283:9814-9819. 10.1074/jbc.M710475200, 2442276, 18283104.
21. Bear JE, Gertler FB. Ena/VASP: towards resolving a pointed controversy at the barbed end. J Cell Sci 2009, 122:1947-1953. 10.1242/jcs.038125, 2723151, 19494122.
22. Ferron F, Rebowski G, Lee SH, Dominguez R. Structural basis for the recruitment of profilin-actin complexes during filament elongation by Ena/VASP. EMBO J 2007, 26:4597-4606. 10.1038/sj.emboj.7601874, 2063483, 17914456.
23. Philippar U, Roussos ET, Oser M, Yamaguchi H, Kim HD, Giampieri S, Wang Y, Goswami S, Wyckoff JB, Lauffenburger DA, Sahai E, Condeelis JS, Gertler FB. A Mena invasion isoform potentiates EGF-induced carcinoma cell invasion and metastasis. Dev Cell 2008, 15:813-828. 10.1016/j.devcel.2008.09.003, 2637261, 19081071.
24. Lanier LM, Gates MA, Witke W, Menzies AS, Wehman AM, Macklis JD, Kwiatkowski D, Soriano P, Gertler FB. Mena is required for neurulation and commissure formation. Neuron 1999, 22:313-325. 10.1016/S0896-6273(00)81092-2, 10069337.
25. Guy CT, Cardiff RD, Muller WJ. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol 1992, 12:954-961. 369527, 1312220.
26. Lin EY, Jones JG, Li P, Zhu L, Whitney KD, Muller WJ, Pollard JW. Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. Am J Pathol 2003, 163:2113-2126. 1892434, 14578209.
27. Menzies AS, Aszodi A, Williams SE, Pfeifer A, Wehman AM, Goh KL, Mason CA, Fassler R, Gertler FB. Mena and vasodilator-stimulated phosphoprotein are required for multiple actin-dependent processes that shape the vertebrate nervous system. J Neurosci 2004, 24:8029-8038. 10.1523/JNEUROSCI.1057-04.2004, 15371503.
28. Kwiatkowski AV, Rubinson DA, Dent EW, Edward van Veen J, Leslie JD, Zhang J, Mebane LM, Philippar U, Pinheiro EM, Burds AA, Bronson RT, Mori S, Fassler R, Gertler FB. Ena/VASP Is Required for neuritogenesis in the developing cortex. Neuron 2007, 56:441-455. 10.1016/j.neuron.2007.09.008, 17988629.
29. Dent EW, Kwiatkowski AV, Mebane LM, Philippar U, Barzik M, Rubinson DA, Gupton S, van Veen JE, Furman C, Zhang J, Alberts AS, Mori S, Gertler FB. Filopodia are required for cortical neurite initiation. Nat Cell Biol 2007, 9:1347-1359. 10.1038/ncb1654, 18026093.
30. Yu TW, Hao JC, Lim W, Tessier-Lavigne M, Bargmann CI. Shared receptors in axon guidance: SAX-3/Robo signals via UNC-34/Enabled and a Netrin-independent UNC-40/DCC function. Nat Neurosci 2002, 5:1147-1154. 10.1038/nn956, 12379860.
31. Bashaw GJ, Kidd T, Murray D, Pawson T, Goodman CS. Repulsive axon guidance: Abelson and Enabled play opposing roles downstream of the roundabout receptor. Cell 2000, 101:703-715. 10.1016/S0092-8674(00)80883-1, 10892742.
32. Strickland P, Shin GC, Plump A, Tessier-Lavigne M, Hinck L. Slit2 and netrin 1 act synergistically as adhesive cues to generate tubular bi-layers during ductal morphogenesis. Development 2006, 133:823-832. 10.1242/dev.02261, 16439476.
33. Sherwood DR. Cell invasion through basement membranes: an anchor of understanding. Trends Cell Biol 2006, 16:250-256. 10.1016/j.tcb.2006.03.004, 16580836.
34. Lanigan F, O'Connor D, Martin F, Gallagher WM. Molecular links between mammary gland development and breast cancer. Cell Mol Life Sci 2007, 64:3159-3184. 10.1007/s00018-007-7386-2, 17955178.
35. Fata JE, Werb Z, Bissell MJ. Regulation of mammary gland branching morphogenesis by the extracellular matrix and its remodeling enzymes. Breast Cancer Res 2004, 6:1-11. 314442, 14680479.
36. Sasmono RT, Oceandy D, Pollard JW, Tong W, Pavli P, Wainwright BJ, Ostrowski MC, Himes SR, Hume DA. A macrophage colony-stimulating factor receptor-green fluorescent protein transgene is expressed throughout the mononuclear phagocyte system of the mouse. Blood 2003, 101:1155-1163. 10.1182/blood-2002-02-0569, 12393599.
37. Ahmed F, Wyckoff J, Lin EY, Wang W, Wang Y, Hennighausen L, Miyazaki J, Jones J, Pollard JW, Condeelis JS, Segall JE. GFP expression in the mammary gland for imaging of mammary tumor cells in transgenic mice. Cancer Res 2002, 62:7166-7169.
38. Neri A, Welch D, Kawaguchi T, Nicolson GL. Development and biologic properties of malignant cell sublines and clones of a spontaneously metastasizing rat mammary adenocarcinoma. J Natl Cancer Inst 1982, 68:507-517.
39. Wyckoff JB, Jones JG, Condeelis JS, Segall JE. A critical step in metastasis in vivo analysis of intravasation at the primary tumor. Cancer Res 2000, 60:2504-2511.
40. Gouon-Evans V, Lin EY, Pollard JW. Requirement of macrophages and eosinophils and their cytokines/chemokines for mammary gland development. Breast Cancer Res 2002, 4:155-164. 10.1186/bcr441, 138736, 12100741.
41. Austyn JM, Gordon S. F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol 1981, 11:805-815. 10.1002/eji.1830111013, 7308288.
42. Kalliomaki TM, McCallum G, Lunt SJ, Wells PG, Hill RP. Analysis of the effects of exposure to acute hypoxia on oxidative lesions and tumour progression in a transgenic mouse breast cancer model. BMC Cancer 2008, 8:151. 10.1186/1471-2407-8-151, 2427038, 18507854.
43. Bucana CD, Fabra A, Sanchez R, Fidler IJ. Different patterns of macrophage infiltration into allogeneic-murine and xenogeneic-human neoplasms growing in nude mice. Am J Pathol 1992, 141:1225-1236. 1886656, 1443054.
44. Movahedi K, Laoui D, Gysemans C, Baeten M, Stange G, Van den Bossche J, Mack M, Pipeleers D, In't Veld P, De Baetselier P, Van Ginderachter JA. Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. Cancer Res 70:5728-5739. 10.1158/0008-5472.CAN-09-4672, 20570887.
45. Lebrand C, Dent EW, Strasser GA, Lanier LM, Krause M, Svitkina TM, Borisy GG, Gertler FB. Critical role of Ena/VASP proteins for filopodia formation in neurons and in function downstream of netrin-1. Neuron 2004, 42:37-49. 10.1016/S0896-6273(04)00108-4, 15066263.
46. Farina KL, Wyckoff JB, Rivera J, Lee H, Segall JE, Condeelis JS, Jones JG. Cell motility of tumor cells visualized in living intact primary tumors using green fluorescent protein. Cancer Res 1998, 58:2528-2532.
47. Wyckoff J, Gligoijevic B, Entenberg D, Segall J, Condeelis J. High resolution multi-photon imaging of tumors in vivo. Live Cell Imaging; A laboratory manual 2010, 1:441-462. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, Goldman RD, Swedlow JR, Spector DL, 2.
48. Sahai E, Wyckoff J, Philippar U, Segall JE, Gertler F, Condeelis J. Simultaneous imaging of GFP, CFP and collagen in tumors in vivo using multiphoton microscopy. BMC Biotechnol 2005, 5:14. 10.1186/1472-6750-5-14, 1159039, 15910685.
49. Wyckoff JB, Segall JE, Condeelis JS. The collection of the motile population of cells from a living tumor. Cancer Res 2000, 60:5401-5404.
50. Osin PP, Anbazhagan R, Bartkova J, Nathan B, Gusterson BA. Breast development gives insights into breast disease. Histopathology 1998, 33:275-283. 10.1046/j.1365-2559.1998.00479.x, 9777395.
51. Schedin P, O'Brien J, Rudolph M, Stein T, Borges V. Microenvironment of the involuting mammary gland mediates mammary cancer progression. J Mammary Gland Biol Neoplasia 2007, 12:71-82. 10.1007/s10911-007-9039-3, 17318269.
52. Dumont N, Crawford YG, Sigaroudinia M, Nagrani SS, Wilson MB, Buehring GC, Turashvili G, Aparicio S, Gauthier ML, Fordyce CA, McDermott KM, Tlsty TD. Human mammary cancer progression model recapitulates methylation events associated with breast premalignancy. Breast Cancer Res 2009, 11:R87. 10.1186/bcr2457, 2815551, 19995452.
53. Cunha GR, Hom YK. Role of mesenchymal-epithelial interactions in mammary gland development. J Mammary Gland Biol Neoplasia 1996, 1:21-35. 10.1007/BF02096300, 10887478.
54. Robinson GW, Karpf AB, Kratochwil K. Regulation of mammary gland development by tissue interaction. J Mammary Gland Biol Neoplasia 1999, 4:9-19. 10.1023/A:1018748418447, 10219903.
55. O'Brien J, Lyons T, Monks J, Lucia MS, Wilson RS, Hines L, Man YG, Borges V, Schedin P. Alternatively activated macrophages and collagen remodeling characterize the postpartum involuting mammary gland across species. Am J Pathol 2010, 176:1241-1255.
56. Lin EY, Nguyen AV, Russell RG, Pollard JW. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 2001, 193:727-740. 10.1084/jem.193.6.727, 2193412, 11257139.
57. Roussos ET, Alford SK, Wyckoff JB, Gligorijevic B, Wang Y, Pozzuto M, Stobezki R, Goswami S, Lauffenburger DA, Bresnick AR, Gertler FB, Condeelis JS. Paracrine signaling between tumor cells and macrophages in vivo is increased by Mena invasive (MenaINV) but not Mena11a isoforms. Cancer Res 2010,
58. Stetler-Stevenson WG, Aznavoorian S, Liotta LA. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 1993, 9:541-573. 10.1146/annurev.cb.09.110193.002545, 8280471.
59. Chang C, Adler CE, Krause M, Clark SG, Gertler FB, Tessier-Lavigne M, Bargmann CI. MIG-10/lamellipodin and AGE-1/PI3K promote axon guidance and outgrowth in response to slit and netrin. Curr Biol 2006, 16:854-862. 10.1016/j.cub.2006.03.083, 16618541.
60. Srinivasan K, Strickland P, Valdes A, Shin GC, Hinck L. Netrin-1/neogenin interaction stabilizes multipotent progenitor cap cells during mammary gland morphogenesis. Dev Cell 2003, 4:371-382. 10.1016/S1534-5807(03)00054-6, 12636918.
61. Strizzi L, Bianco C, Raafat A, Abdallah W, Chang C, Raafat D, Hirota M, Hamada S, Sun Y, Normanno N, Callahan R, Hinck L, Salomon D. Netrin-1 regulates invasion and migration of mouse mammary epithelial cells overexpressing Cripto-1 in vitro and in vivo. J Cell Sci 2005, 118:4633-4643. 10.1242/jcs.02574, 16176936.
62. Matus DQ, Li XY, Durbin S, Agarwal D, Chi Q, Weiss SJ, Sherwood DR. In vivo identification of regulators of cell invasion across basement membranes. Sci Signal 3:ra35. 10.1126/scisignal.2000654, 20442418.
63. Schedin P, Borges V. Breaking down barriers: the importance of the stromal microenvironment in acquiring invasiveness in young women's breast cancer. Breast Cancer Res 2009, 11:102. 10.1186/bcr2235, 2688940, 19344495.
64. Pinder SE. Ductal carcinoma in situ (DCIS): pathological features, differential diagnosis, prognostic factors and specimen evaluation. Mod Pathol 2010, 23:S8-13. 10.1038/modpathol.2010.40, 20436505.